Paradoxical psoriasis caused by tumour necrosis factor inhibitor therapy

Clinical and Experimental Dermatology ◽

10.1111/ced.14500 ◽

2020 ◽

Author(s):

J. M. E. Boggs ◽

B. Ramsay ◽

M. Lynch

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study

10.1136/annrheumdis-2017-eular.4787 ◽

2017 ◽

Author(s):

J Rech ◽

M Hagen ◽

M Englbrecht ◽

J Haschka ◽

M Reiser ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Sustained Remission ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Defective CD8+CD28−regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Clinical & Experimental Immunology ◽

10.1111/cei.12161 ◽

2013 ◽

Vol 174 (1) ◽

pp. 18-26 ◽

Author(s):

S. Ceeraz ◽

C. Hall ◽

E. H. Choy ◽

J. Spencer ◽

V. M. Corrigall

Keyword(s):

Rheumatoid Arthritis ◽

T Cell ◽

Tumour Necrosis Factor ◽

Regulatory T Cell ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Suppressor Function ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

248 Sustained improvements in disease activity for up to two-years with ixekizumab in patients with active psoriatic arthritis who were either biologic-naïve or with previous inadequate response to tumour necrosis factor inhibitor therapy

Rheumatology ◽

10.1093/rheumatology/kez107.064 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

Deepak R Jadon ◽

Mani Haschemi Nassab ◽

Katrien Van Beneden ◽

Georg Pum ◽

Andrew J Bradley

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Inadequate Response ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort

Rheumatology ◽

10.1093/rheumatology/keu255 ◽

2014 ◽

Vol 54 (1) ◽

pp. 152-156 ◽

Author(s):

D. Wallis ◽

A. Thavaneswaran ◽

N. Haroon ◽

R. Ayearst ◽

R. D. Inman

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Infection Risk ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Observational Cohort ◽

Necrosis Factor

Download Full-text

OP0106 The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

10.1136/annrheumdis-2017-eular.1500 ◽

2017 ◽

Author(s):

C Ballegaard ◽

P Højgaard ◽

L Dreyer ◽

R Cordtz ◽

TS Jørgensen ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

THU0332 Fatigue remains a dominatng symptom despite tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

10.1136/annrheumdis-2018-eular.6780 ◽

2018 ◽

Author(s):

T.S. Jørgensen ◽

M. Skougaard ◽

C. Ballegaard ◽

P. Mease ◽

V. Strand ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

O11 Drug-Specific Risk and Associated Factors with Vasculitis-Like Events in Patients Exposed to Tumour Necrosis Factor Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology ◽

10.1093/rheumatology/kew120.004 ◽

2016 ◽

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Associated Factors ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

British Society ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Biologics Register

Download Full-text

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-203407 ◽

2013 ◽

Vol 73 (11) ◽

pp. 1942-1948 ◽

Author(s):

John W Baddley ◽

Kevin L Winthrop ◽

Lang Chen ◽

Liyan Liu ◽

Carlos G Grijalva ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Safety Assessment ◽

Biologic Therapy ◽

Opportunistic Infections ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study

BMC Rheumatology ◽

10.1186/s41927-020-0118-z ◽

2020 ◽

Vol 4 (1) ◽

Author(s):

A. Deodhar ◽

V. Strand ◽

P. G. Conaghan ◽

E. Sullivan ◽

S. Blackburn ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Unmet Needs ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs

Clinical Rheumatology ◽

10.1007/s10067-017-3961-6 ◽

2018 ◽

Vol 37 (4) ◽

pp. 909-916 ◽

Author(s):

Gerard A. Rongen ◽

Iris van Ingen ◽

Marc Kok ◽

Harald Vonkeman ◽

Matthijs Janssen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text